Physician profile
Sydnee Nelson
NPI 1356802003
$619.40
in general payments reported to CMS, 2019-2025
16 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $63.24 · 2023: $74.15 · 2024: $217 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $91.43 | 2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $67.55 | 2022-2024 | |
| Pfizer INC. | $61.90 | 2025 | |
| Novo Nordisk INC | $59.28 | 2024-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.53 | 2022-2024 | Jardiance |
| Mylan Specialty L.P. | $43.12 | 2022-2023 | Yupelri |
| Dexcom, INC. | $38.49 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $29.89 | 2023-2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $28.46 | 2023-2024 | Farxiga |
| Exact Sciences Corporation | $27.76 | 2023-2024 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $22.83 | 2025 | |
| Insulet Corporation | $21.99 | 2025 | Omnipod |
| Tactile Systems Technology INC | $19.06 | 2025 | Flexitouch Plus, Nimbl |
| Edwards Lifesciences Corporation | $18.93 | 2023 | Sapien 3 Ultra Resilia |
| Abbvie INC. | $17.77 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.41 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydnee Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.